Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197288 · ClinicalTrials.gov registry record · Phase 3
Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,847
- Enrollment target
NCT00197288: Completed Phase 3 study, sponsored by GlaxoSmithKline.
NCT00197288 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 1,847 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (139% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00197288, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,847 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two licensed influenza vaccines (Fluzone and Fluarix) in terms of the immune response elicited and the safety/ any symptoms that may occur for up to six months after vaccination.
Interventions
- BIOLOGICAL Influenza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,847 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
What the finished NCT00197288 record still lists
NCT00197288 is an interventional study that assigns participants to a tested intervention. Its 1,847 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (139% higher).
The record links to 0 conditions, and to 1 intervention - of which Influenza is the first listed.
NCT00197288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00197288 about?
NCT00197288 is a clinical study titled "Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines". The purpose of this study is to compare two licensed influenza vaccines (Fluzone and Fluarix) in terms of the immune response elicited and the safety/ any symptoms that may occur for up to six months after vaccination.
What is the current status of trial NCT00197288?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,847 participants. The study started on 2005-10. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00197288?
The interventions under investigation include: Influenza (BIOLOGICAL).
Who is sponsoring clinical trial NCT00197288?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00197288's enrollment target sits among peer trials
1,847 114th of 2000 higher than 1,887 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia